Robuta

https://pubmed.ncbi.nlm.nih.gov/36689579/
FHT almost doubles the odds of excellent clinical outcome without increased risk compared with later treatment, which supports the use of MSUs.
golden hourplasminogen activatortreatmenttpatissue
https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2010/02/23/19/17/RAAMI
plasminogen activatorrandomizedangiographictrialrecombinant
https://www.jci.org/articles/view/115069/scanned-page/1088
fibrin degradation productstissue plasminogen activatorjcisolubleinduced